FDA warns of another compounding pharmacy recall

(AP)—The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.

The FDA say Georgia-based Clinical Specialties has received five reports of from physicians who used the drug to treat macular degeneration, a common vision disorder that affects seniors.

The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since December.

Avastin is approved as a cancer drug, but it contains the same active ingredient as Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors. Repackaged injections of cost about $50, compared with $2,000 for Lucentis.


Explore further

Cheaper eye drug proves as good as pricier one

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA warns of another compounding pharmacy recall (2013, March 20) retrieved 26 November 2020 from https://medicalxpress.com/news/2013-03-fda-compounding-pharmacy-recall.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments